Zdrowie i gospodarka · 19/12/2017
FDA Classifies Tear Electrostimulation Device into Class II with Special Controls
The FDA has classified the tear electrostimulation device into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →